Literature DB >> 18709370

[Differential diagnosis of synovitis].

L Morawietz1, G Fernahl, V Krenn.   

Abstract

The synovial membrane is a site where many diseases with different etiologies can become manifest. Tumors and storage diseases are some of the rare conditions, whereas crystal deposition diseases, acute bacterial infections and in particular chronic uncharacteristic synovitis are frequently encountered. The latter present a diagnostic problem, because they can barely be assigned to concrete diagnoses. This report will give an overview of the differential diagnosis of joint diseases and will focus on the so-called synovitis score as a tool for the systematic evaluation of chronic uncharacteristic synovitis, providing a possibility to differentiate between degenerative and rheumatic synovitis with a specificity of 60.5% and a sensitivity of 95.5%.

Entities:  

Mesh:

Year:  2008        PMID: 18709370     DOI: 10.1007/s00292-008-1036-9

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  11 in total

1.  Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis.

Authors:  H J Kim; V Krenn; G Steinhauser; C Berek
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

2.  INFLAMMATORY REACTION AFTER INTRASYNOVIAL INJECTION OF MICROCRYSTALLINE ADRENOCORTICOSTEROID ESTERS.

Authors:  D J MCCARTY; J M HOGAN
Journal:  Arthritis Rheum       Date:  1964-08

3.  Synovitis score: discrimination between chronic low-grade and high-grade synovitis.

Authors:  V Krenn; L Morawietz; G-R Burmester; R W Kinne; U Mueller-Ladner; B Muller; T Haupl
Journal:  Histopathology       Date:  2006-10       Impact factor: 5.087

4.  [Synovialitis score: histopathological grading system for chronic rheumatic and non-rheumatic synovialitis].

Authors:  V Krenn; L Morawietz; G-R Burmester; T Häupl
Journal:  Z Rheumatol       Date:  2005-06       Impact factor: 1.372

5.  Proposal for a histopathological consensus classification of the periprosthetic interface membrane.

Authors:  L Morawietz; R-A Classen; J H Schröder; C Dynybil; C Perka; A Skwara; J Neidel; T Gehrke; L Frommelt; T Hansen; M Otto; B Barden; T Aigner; P Stiehl; T Schubert; C Meyer-Scholten; A König; P Ströbel; C P Rader; S Kirschner; F Lintner; W Rüther; I Bos; C Hendrich; J Kriegsmann; V Krenn
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

6.  [Differential diagnosis of synovitis. Correlation of arthroscopic-biopsy to clinical findings].

Authors:  E Schulte; A Fisseler-Eckhoff; K M Müller
Journal:  Pathologe       Date:  1994-02       Impact factor: 1.011

7.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

8.  Computer-assisted validation of the synovitis score.

Authors:  Lars Morawietz; Frank Schaeper; Joerg H Schroeder; Tserenchunt Gansukh; Nachin Baasanjav; Manfred G Krukemeyer; Thorsten Gehrke; Veit Krenn
Journal:  Virchows Arch       Date:  2008-02-19       Impact factor: 4.064

9.  Synovitis with non-specific histological changes in synovium in chronic sarcoidosis.

Authors:  D G Palmer; H R Schumacher
Journal:  Ann Rheum Dis       Date:  1984-12       Impact factor: 19.103

10.  Brucella arthritis.

Authors:  A P Andonopoulos; G Asimakopoulos; E Anastasiou; H P Bassaris
Journal:  Scand J Rheumatol       Date:  1986       Impact factor: 3.641

View more
  3 in total

Review 1.  [Tendinopathy in rheumatic diseases].

Authors:  M Henniger; S Rehart
Journal:  Unfallchirurg       Date:  2017-03       Impact factor: 1.000

2.  Bleeding complications after arthroscopy in a JAK2V617F-positive patient with essential thrombocythemia and acquired von Willebrand syndrome (AVWS).

Authors:  Joanna Rupa-Matysek; Krzysztof Lewandowski; Maria Lewandowska; Ewelina Wojtasińska; Marzena Liliana Wojtaszewska; Michał Walczak; Ksenia Bykowska; Mieczysław Komarnicki
Journal:  Int J Hematol       Date:  2014-11-29       Impact factor: 2.490

Review 3.  [Approach to joint effusion].

Authors:  M Henniger; S Rehart
Journal:  Orthopade       Date:  2016-09       Impact factor: 1.087

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.